Virtual Medicinal Product (VMP) - Efalizumab 125mg powder and solvent for solution for injection vials

Navigation

Name Details

Name Start Date End Date
Name Current Name Efalizumab 125mg powder and solvent for solution for injection vials Start Date 03-11-2004 End Date
Abbreviated Name Abbreviated Name Efalizumab 125mg inj vials Start Date 01-05-2009
Previous Abbreviated Name Efalizumab 125mg pdr & solv for soln for inj vials Previous Start Date 03-11-2004 Previous End Date 30-04-2009

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1.0
UDFS UOM
vial
Unit Dose UOM
vial

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Subcutaneous
Form
Powder and solvent for solution for injection
Ontology Form/Route
solutioninjection.subcutaneous
Non-availability Indicator
Actual Products not Available
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
L04AA21
BNF Start Date End Date
Current BNF 13050300 Start Date 04-04-2022 End Date
Previous BNF 13050300 Start Date 07-04-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
8285111000001106 03-11-2004

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Efalizumab Based on Ingredient Substance 125 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
1 vial
4 vial